BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2025 8:05:38 AM | Browse: 498 | Download: 463
 |
Received |
|
2025-04-30 03:45 |
|
Peer-Review Started |
|
2025-04-30 03:45 |
|
First Decision by Editorial Office Director |
|
2025-05-30 18:28 |
|
Return for Revision |
|
2025-05-30 18:28 |
|
Revised |
|
2025-06-27 15:07 |
|
Publication Fee Transferred |
|
2025-06-30 13:43 |
|
Second Decision by Editor |
|
2025-08-11 02:49 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-08-12 10:09 |
|
Articles in Press |
|
2025-08-12 10:09 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-25 00:43 |
|
Publish the Manuscript Online |
|
2025-09-01 08:05 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Methotrexate in the management of Crohn’s disease: A practice survey of gastroenterologists in France
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Guillaume Bonnaud, Jennifer Becker, Myriam Chebbah, Agnès Courbeyrette and Patrick Faure |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Patrick Faure, Hépato-Gastro-Entérologie, Clinique Pasteur, 45 Av. de Lombez BP, Toulouse 31076, France. pfaure@clinique-pasteur.com |
| Key Words |
Methotrexate; Crohn’s disease; Combination therapy; Immunosuppressant; Azathioprine; Guidelines; France; Practice survey; Real-world evidence |
| Core Tip |
This practice survey among French gastroenterologists reveals a growing confidence in methotrexate (MTX) for managing Crohn’s disease (CD), particularly in combination with biologics for specific patient profiles such as those with joint involvement or Epstein-Barr virus negativity. While MTX is often underutilized compared to azathioprine, respondents acknowledged its favorable long-term safety profile. The study highlights variability in prescribing habits and underlines the need for clearer clinical guidelines and more real-world evidence to support optimal use of MTX in CD. |
| Publish Date |
2025-09-01 08:05 |
| Citation |
Bonnaud G, Becker J, Chebbah M, Courbeyrette A, Faure P. Methotrexate in the management of Crohn’s disease: A practice survey of gastroenterologists in France. World J Gastroenterol 2025; 31(33): 108872 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i33/108872.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i33.108872 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
